CharacTeristics of treAtment response to hIgh dose ICS/LABA vs. Medium or high dOse ICS/LABA + LAMA in patients with uncontRolled moderate to severe asthma on medium dose ICS/LABA - TAILOR study First published 19/11/2021 Last updated 02/05/2024 EU PAS number:EUPAS39039 Study Ongoing